Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

US PRECISION Implementation Study

ClinicalTrials.gov ID: NCT04891978

Public ClinicalTrials.gov record NCT04891978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Implementation of the US PRECISION AIRQ, Asthma Checklist, and Educational Resources (PRECISION Program) Into Clinical Practice Using Telehealth and In-Person Platforms

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this community program intervention study is to assess the process and potential benefits of integrating the AIRQ®, Asthma Checklist, and educational resources (PRECISION program) into clinical practice using either in-person or telehealth visits. The secondary objectives are to assess asthma patients' clinic visit experiences when the AIRQ, the Asthma Checklist, and educational resources (PRECISION program) are utilized as part of a telehealth or in-person visit with their HCP, and to explore change in AIRQ scores from the initial visit to follow-up visit(s) (when available).

Study identification

NCT ID
NCT04891978
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
AstraZeneca
Industry
Enrollment
857 participants

Conditions and interventions

Conditions

Interventions

Behavioral

Eligibility (public fields only)

Age range
13 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 20, 2021 (Actual)
Primary completion
Apr 30, 2023 (Actual)
Completion
Apr 30, 2023 (Actual)
Last update posted
Jul 8, 2025

2021 – 2023

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209 —
Research Site Leesburg Florida 34748 —
Research Site Honolulu Hawaii 96819 —
Research Site Fort Wayne Indiana 46802 —
Research Site Tewksbury Massachusetts 01876 —
Research Site Ann Arbor Michigan 48109 —
Research Site Cornwall-on-Hudson New York 12518 —
Research Site Rochester New York 14607 —
Research Site Asheville North Carolina 28801 —
Research Site Philadelphia Pennsylvania 19148 —
Research Site San Antonio Texas 78249 —
Research Site Vienna Virginia 22182 —
Research Site Charleston West Virginia 25304 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04891978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04891978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →